Should HCQ be continued in an asymptomatic SLE patient who has received renal transplant?

As far as I know there is not a definitive answer to this question due to a lack of clinical trials. My approach is to continue it at a dose adjusted for renal failure. My thought process is that both lupus and chronic renal failure increase the risk of cardiovascular events significantly. Plaquenil...

I agree, @Dr. First Last about the lack of good science on this topic and that it could help reduce CV events (a huge problem in this patient population.

However, being a betting man (which I am), I bet it would reduce flare rates and improve disease activity compared to patients who do not continue ...